Journalartikel

Islet transplantation: Present clinical situation and future aspects


AutorenlisteBretzel, RG; Brendel, M; Eckhard, M; Brandhorst, D; Jaeger, C; Hatziagelaki, E; Federlin, K

Jahr der Veröffentlichung2001

SeitenS384-S399

ZeitschriftExperimental and Clinical Endocrinology & Diabetes

Bandnummer109

ISSN0947-7349

eISSN1439-3646

DOI Linkhttps://doi.org/10.1055/s-2001-18597

VerlagThieme Publishing


Abstract
Beta-cell replacement either by pancreatic organ or islet cell transplantation is the only treatment to achieve an insulin-independent, normoglycemic state and to avoid hypoglycemic episodes in patients with type 1 diabetes mellitus, This article will review the state-of-the-art in clinical islet cell personal experience. transplantation at the dawn of the new millenium and will provide an outlook on the basis of extended personal experience.



Zitierstile

Harvard-ZitierstilBretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., et al. (2001) Islet transplantation: Present clinical situation and future aspects, Experimental and Clinical Endocrinology & Diabetes, 109, pp. S384-S399. https://doi.org/10.1055/s-2001-18597

APA-ZitierstilBretzel, R., Brendel, M., Eckhard, M., Brandhorst, D., Jaeger, C., Hatziagelaki, E., & Federlin, K. (2001). Islet transplantation: Present clinical situation and future aspects. Experimental and Clinical Endocrinology & Diabetes. 109, S384-S399. https://doi.org/10.1055/s-2001-18597



Schlagwörter


ACID DECARBOXYLASE ANTIBODIESALLOGRAFT SURVIVALalloimmunityAUTOIMMUNITYCELL ANTIBODIESDIABETES-MELLITUSDONORGene therapyimmunotoleranceINSULIN INDEPENDENCEISLET TRANSPLANTATIONKidney transplantationLONG-TERM SURVIVALPANCREATIC-ISLET


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:45